版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
IntroductiontoTPN新光吳火獅紀(jì)念醫(yī)院內(nèi)科部胃腸肝膽科柯威旭醫(yī)師第1頁(yè)NutritionSupportTeamPhysiciansClinicalpharmacistsNurse-CliniciansDietitiansLaboratoryresearchtechnicianWardnursingstaffInSKH:主任,執(zhí)行秘書,各科醫(yī)師,藥劑師,營(yíng)養(yǎng)師第2頁(yè)SourceofNutritionEnteralnutritionParenteralnutritionCentralparenteralnutrition(CPN=TPN)Peripheralparenteralnutrition(PPN)Long-termhomeparenteralnutrition(HPN)第3頁(yè)ClinicaldecisionalgorithmrouteofnutritionsupportDecisiontoinstitutespecial
nutritionsupport
OralFeedingNutritionAssessmentFunctionalGITractEnteralNutritionParenteralNutritionGIfunctionPPNTPNGIfunctionreturnIntactNutrientsDefinedFormulaAdequateInadequatePNShort-term:NG,ND,NJLong-term:GastrostomyJejunostomyYESNONOYESAdequate第4頁(yè)P(yáng)PNHighriskofthrombophlebitisOsmolarity:lessthan800-900mOsm/kgShort-term:upto2weeksNottheoptimalchoiceforsignificantmalnutritionseveremetabolicstresslargenutrientorelectrolyteneeds(especiallypotassium,astrongvascularirritant)fluidrestrictiontheneedforprolongedintravenousnutritionsupport
第5頁(yè)IndicationsofTPNImpossibilityforenteralnutritionInadequacyforenteralnutritionIncrementoftheseverityofdiseasebyenteralnutritionPLUSAnticipatedtohavePNformorethan7days第6頁(yè)TPNinInternalMedicineAcutepancreatitisIntestinaldisease(IBD,NEC,radiationcolitis,ileus,intractablediarrhea/vomiting)CancerHepaticfailureRenalfailureShortbowelsyndromeEnterocutaneousfistulaAIDSPerioperativesupport第7頁(yè)TPNshouldnotbeusedinMalignancy:poorresponsetoR/TorC/TActivestageofIBDRelativepreservedGIfunctionHypertriglyceridemia(TG>400md/dl)第8頁(yè)ComponentsofTPNCarbohydrate,Aminoacid,Fat,Electrolyte,Water,Vitamin,TraceelementStandardsolutionDextrose,AminoacidElectrolyte(Na,K,Cl,Mg,Ca,P)Vitamin(A,B1,B2,Niacin,B6,Panthothenicacid,C,D,E,Zn,Cu,Mn,Cr)Lipidemulsion第9頁(yè)Dextrose-contentSolution1gglucose=3.4Kcal1gglucose=5mOsm/L第10頁(yè)Aminoacidsolution7%A.A.含essentialA.A.較高,適用於腎衰竭病患8%A.A.含高濃度branchchainA.A.,低濃度aromaticA.A.,可使肝衰竭病患之HE改善12%A.A.成人StandardSolution之A.A.來源第11頁(yè)Lipidemulsions10%intralipid20%intralipid10%lipofundinVolume500ml/B250ml/B100ml/BCalorie550Kcal/B500Kcal/B110Kcal/B第12頁(yè)TPNformulaB:standardsolutionD:8%A.A.,highBCAA,lowAAA;forhepaticdiseaseE:35%Dextrose,12%A.A.;forHDandwaterrestrictionF:29%Dextrose,12%&7%A.A.;forARFwithHDG:29%Dextrose,7%A.A.;forESRD第13頁(yè)TPNOrder第14頁(yè)VascularAccessforTPNCareComplicationInfectionSubclavianveinEasyHighLowInternaljugularveinHardLowHighFemoralveinHardLowHighestAntecubitalveinEasyLowHigh第15頁(yè)MechanicalcomplicationInsertion-of-catheterrelated:pneumothorax,brachialplexusinjury,subclavianandcarotidarterypuncture,hemothorax,thoracicductinjuryandchylothorax,cardiacperforation,cathetermalpositionAirembolismCatheterfragmentembolism第16頁(yè)MetaboliccomplicationFluidoverload/DehydrationfromosmoticdiuresisHypertriglyceridemiaHypocalcemiaHypomagnesemiaHypophosphatemiaHyperglycemia/ReboundhypoglycemiaonsuddencessationofTPNHyperammonemiaHyperchloremicmetabolicacidosisNKHS第17頁(yè)InfectiouscomplicationCatheter-relatedsepsis:Staph.epidermidisandaureus;solutioncontaminationGNBforimmunocompromiseDirectevidence:tipcultureorbloodcultureIndirectevidence:fever(upto38C,2times,every4hours),chills,abruptincreaseofbloodsugar,hypotension,tachycardia,leukocytosis第18頁(yè)HepaticcomplicationBiochemical:elevatedserumaminotransferaseandalkalinephosphataseHistological:steatosis,steatohepatitis,cholestasis,fibrosisandcirrhosisUsuallybenignandtransient,butsevereinTPNfor>16weeksAdditiveuseofCholine,GlutamineandCarnitinemaybehelpfulIfcholestasisispresent,CuandMgshouldbedeletedtopreventacculumationinliverandBG第19頁(yè)BiliarycomplicationAcalculouscholecystitis,GBsludge,cholelithiasisinTPNfor>3weeksDecreaseofbilesaltreabsorptionleadstoformationofGBstone;EncouragingenteralintaketostimulateGBcontraction第20頁(yè)IntestinalcomplicationVillousatrophy:decreasesingutweightandmucosalheight第21頁(yè)MetabolicbonediseasePresentinTPNfor>3monthsBonepain,bonefractureorasymptomaticbutdemineralizationinCxRPossiblemechanismsAluminumtoxicityVitaminDtoxicityNegativecalciumbalance第22頁(yè)RefeedingsyndromeThemetabolicandphysiologicconsequencesofthedepletion,repletion,compartmentalshiftsandinterrelationshipsofthefollowingsPhosphorus(<1mg/dl,deathwithinhours)PotassiumMagnesiumGlucosemetabolismVitamindeficiencyFluidresuscitation第23頁(yè)CaseHistory66y/ofemale,abdominalpainandanorexiafor6weekspersistentprofuse,yellow,waterydiarrheaafterconstructionanilealconduitforureteralobstructionlastingfor3monthsPE:BW36kg,70%ofIBW;afebrile,108,14,98/70anasarca,cachecticwithgeneralizedmusclewastage第24頁(yè)Hct38%,WBC17000,BUN/Cr22/1.0,K3.4,P3.4,HCO317,Sugar48,Alb.1.59HospitalCourseTPNwasstartedwith750gdextrose,120gAA,60mEqNa,20mEqK,15mmolPin3Lfluid24hrsafterstartofTPN,HR180,SBP50,CVP<3cmH2OP0.7,Na142,K1.4,HCO319,Mg1.8,Sugar1010,BUN/Cr27/1.3pH7.31,O259,CO224(O22L)第25頁(yè)ApneaandrespiratoryfailuredevelopedwithinonehourWithstoppingTPNandfluidreplacement,P6.9,K3.5andSugar45wereobtained.Inthefollowinghospitalization,bilateralpneumoniaandARDSwerecomplicated.Diedonthe6thdayAutopsy:ischemicenterocolitis,pneumonia,ARDSandperitonitisandtheheartwasunremarkable第26頁(yè)第27頁(yè)SequenceofeventsP,Sugar,K,Meta.acidosisGIbleeding,SepsisTachycardia,HypotensionApnea,MVsupportARDS,PneumoniaPersistentCardiopulmonaryInstabilityDeathWithin48hrsofstartingTPNAftercorrectionofhypophosphatemia第28頁(yè)P(yáng)hysiologyofStarvationWhenBMR=energyoutputtothelimitedintake,endogenousfuelsmustbeusedMajorstoragefuelisfatinformofTG(60-75days)Carbohydrate,incontrast,isquantitativelyinsignificantstoragefuel(1200kcal,1day’srestingER)Protein,12kg,2weeks’worthofcalories;butisfornonfuelfunction第29頁(yè)MetabolicResponsetoRefeedingAshiftfrombodyfattoCHOasmajorfuelsourceInsulinGlycogenolysis,gluconeogenesisandFAmobilizationfromadiposetissueisinhibitedCellularuptakeofglucose,K,P,andMgisenhancedbyinsulinAntinatriureticeffect(NaretentionandECFexpansion)第30頁(yè)P(yáng)atientofriskforrefeedi
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- GB/Z 44938.2-2024機(jī)械電氣安全第2部分:保護(hù)人員安全的傳感器的應(yīng)用示例
- α-Apooxytetracycline-生命科學(xué)試劑-MCE-3621
- PB-22-7-Hydroxyisoquinoline-isomer-生命科學(xué)試劑-MCE-3092
- L-Arginyl-L-alanine-生命科學(xué)試劑-MCE-1970
- BDW-OH-生命科學(xué)試劑-MCE-6441
- 4-Chlorocathinone-hydrochloride-生命科學(xué)試劑-MCE-4146
- 1-Methyl-3-amino-4-cyanopyrazole-生命科學(xué)試劑-MCE-7778
- 2025年度智能城市基礎(chǔ)設(shè)施合作框架協(xié)議
- 二零二五年度茶葉種植基地租賃與經(jīng)營(yíng)管理合同
- 二零二五年度貨車駕駛員勞動(dòng)合同(貨車駕駛與車輛融資租賃)
- 2024-2025學(xué)年成都市金牛區(qū)九年級(jí)上期末(一診)英語(yǔ)試題(含答案)
- 2025年高壓電工資格考試國(guó)家總局模擬題庫(kù)及答案(共四套)
- 人教版高中英語(yǔ)必修一單詞表(默寫版)
- 格式塔心理學(xué)與文藝心理學(xué)
- (汽車制造論文)機(jī)器人在汽車制造中應(yīng)用
- 幼兒園手工教學(xué)中教師指導(dǎo)行為研究-以自貢市幼兒園為例
- 初中物理實(shí)驗(yàn)教學(xué)
- 《智能投顧 大數(shù)據(jù)智能驅(qū)動(dòng)投顧創(chuàng)新》讀書筆記思維導(dǎo)圖
- 企業(yè)應(yīng)急管理及能力提升培訓(xùn)課件精選
- 吲哚菁綠血管造影檢查知情同意書
- 最新婚姻家庭心理講座主題講座課件
評(píng)論
0/150
提交評(píng)論